Piermont Capital Management’s Axcelis ACLS Stock Holding History

Piermont Capital Management’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,860	Closed	-$314K	–	114
2018 Q2	$314K	Buy	+15,860	New	+$349K	0.1%	205

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Piermont Capital Management's ACLS Position: Q3 2018 in Review

Piermont Capital Management sold out of Axcelis (ACLS) in Q3 2018, closing a stake of 15,860 shares — an estimated $314K sold.

Piermont Capital Management first reported a position in ACLS in Q2 2018 and held it in 1 quarter. The position peaked at $314K in Q2 2018. 154 funds tracked by Wall St. Rank hold ACLS as of Q3 2018.

Piermont Capital Management reported no remaining Axcelis position as of Q3 2018 after selling out during the quarter.
Piermont Capital Management sold 15,860 Axcelis shares in Q3 2018, an estimated $314K.
Piermont Capital Management first reported a position in Axcelis in Q2 2018 and held it in 1 quarter.
Piermont Capital Management's Axcelis position peaked at $314K in Q2 2018.
154 funds tracked by Wall St. Rank held Axcelis as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.